15-63057049-C-A
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM1PM2PP2PP3_Moderate
The ENST00000403994.9(TPM1):c.305C>A(p.Ala102Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A102T) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000403994.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TPM1 | NM_001018005.2 | c.305C>A | p.Ala102Asp | missense_variant | 3/10 | ENST00000403994.9 | NP_001018005.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TPM1 | ENST00000403994.9 | c.305C>A | p.Ala102Asp | missense_variant | 3/10 | 1 | NM_001018005.2 | ENSP00000385107 | A1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Dec 23, 2010 | Variant classified as Uncertain Significance - Favor Pathogenic. The Ala102Asp v ariant has not been reported in the literature. Alanine (Ala) at position 102 i s highly conserved across mammals (alignments were not available for more evolut ionary distant species), increasing the likelihood that the change is pathogenic . Our laboratory has previously detected this variant in one HCM proband who car ried an additional variant. One affected family member carried the Ala102Asp va riant in silation, which is consistent with a pathogenic role. In addition, the variant was predicted to be pathogenic using a novel computational tool (a cust omized sarcomere-specific PolyPhen tool, which was validated using a set of card iomyopathy variants with well-established clinical significance). This tool's pa thogenic prediction is estimated to be correct 94% of the time, which suggests b ut does not prove that this variant is pathogenic. However, additional evidence (such as absence in healthy controls) is needed to determine the clinical signif icance of this variant with certainty. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at